Last reviewed · How we verify

NCT04170569

Yoga on Posttraumatic Growth and Quality of Life

Completed NA Last updated 20 November 2019
What this trial tests

NA trial testing Yoga in Posttraumatic Growth in 80 participants. Completed in 19 January 2019.

Timeline
19 October 2017
Primary endpoint
19 January 2018
19 January 2019

Quick facts

Lead sponsorInonu University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposesupportive care
Enrollment80
Start date19 October 2017
Primary completion19 January 2018
Estimated completion19 January 2019
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Inonu University

Who can join

Adults 18 to 35, female only, with Posttraumatic Growth or Quality of Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to examine the effect of yoga on posttraumatic growth and quality of life. The birth action, which includes positive and negative experiences, can be an important opportunity to achieve posttraumatic growth and improve the quality of life. This is a experimental model with pretest-posttest control group study. Two hundred and fifty-two women who met the criteria for inclusion in the study made up the research population. Three instruments were used to obtain the research data: Personal Information Form, Posttraumatic Growth Inventory (PTGI) and SF-36 Quality of Life Questionnaire (SF-36).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Yoga

Trials testing the same drug.

Other recruiting trials for Posttraumatic Growth

Currently open trials in the same condition.

Other Inonu University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04170569.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing